Beijing Biostar Pharmaceuticals Co., Ltd. (02563)
Beijing Biostar Pharmaceuticals Co., Ltd., a synthetic biology-driven biopharmaceutical company, engages in the research, development, manufacture, and commercialization of oncology products in the People's Republic of China. The company develops Utidelone injection, a microtubule inhibitor for the treatment of advanced and neoadjuvant breast cancer, advanced non-small cell lung cancer, gastric and esophageal cancer, brain
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
